Roscovitine and purvalanol A effectively reverse anthracycline resistance mediated by the activity of aldo-keto reductase 1C3 (AKR1C3): A promising therapeutic target for cancer treatment

2018 ◽  
Vol 156 ◽  
pp. 22-31 ◽  
Author(s):  
Eva Novotná ◽  
Neslihan Büküm ◽  
Jakub Hofman ◽  
Michaela Flaxová ◽  
Etela Kouklíková ◽  
...  
2015 ◽  
Vol 78 (11) ◽  
pp. 2666-2674 ◽  
Author(s):  
Lucie Zemanova ◽  
Jakub Hofman ◽  
Eva Novotna ◽  
Kamil Musilek ◽  
Tereza Lundova ◽  
...  

RSC Advances ◽  
2018 ◽  
Vol 8 (37) ◽  
pp. 20692-20700
Author(s):  
Wenhe Zhu ◽  
Wei Zhang ◽  
Na Xu ◽  
Yawei Li ◽  
Junjie Xu ◽  
...  

Cancer cell promotion of glycolysis provides a promising therapeutic target for cancer treatment.


2013 ◽  
Vol 4 (10) ◽  
pp. e838-e838 ◽  
Author(s):  
X Sui ◽  
R Chen ◽  
Z Wang ◽  
Z Huang ◽  
N Kong ◽  
...  

2019 ◽  
Author(s):  
Silvia Scaricamazza ◽  
Illari Salvatori ◽  
Giacomo Giacovazzo ◽  
Jean Philippe Loeffler ◽  
Frederique Renè ◽  
...  

2021 ◽  
Author(s):  
Johannes Burtscher ◽  
Muhammed Muazzam Kamil Syed ◽  
Hilal A. Lashuel ◽  
Grégoire P. Millet

Author(s):  
Marco Spreafico ◽  
Alicja M. Gruszka ◽  
Debora Valli ◽  
Mara Mazzola ◽  
Gianluca Deflorian ◽  
...  

2014 ◽  
Vol 18 (4) ◽  
pp. 403-414 ◽  
Author(s):  
Shinya Matsuzaki ◽  
Satoshi Serada ◽  
Akiko Morimoto ◽  
Yutaka Ueda ◽  
Kiyoshi Yoshino ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document